Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab).
about
Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Validation of an automated met ...... ) and Herceptin (trastuzumab).
@en
Validation of an automated met ...... ) and Herceptin (trastuzumab).
@nl
type
label
Validation of an automated met ...... ) and Herceptin (trastuzumab).
@en
Validation of an automated met ...... ) and Herceptin (trastuzumab).
@nl
prefLabel
Validation of an automated met ...... ) and Herceptin (trastuzumab).
@en
Validation of an automated met ...... ) and Herceptin (trastuzumab).
@nl
P2093
P2860
P356
P1476
Validation of an automated met ...... ) and Herceptin (trastuzumab).
@en
P2093
Bas J M Peters
Ewoudt M W van de Garde
Martinus A H Capelle
Tudor Arvinte
P2860
P304
P356
10.4161/MABS.22873
P577
2012-12-19T00:00:00Z